12-50674556-C-A
Variant summary
Our verdict is Likely benign. The variant received -4 ACMG points: 2P and 6B. PM2BP4_ModerateBS2
The NM_173602.3(DIP2B):c.723C>A(p.Asp241Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000342 in 1,461,880 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_173602.3 missense
Scores
Clinical Significance
Conservation
Publications
- intellectual disability, FRA12A typeInheritance: AD, Unknown Classification: LIMITED, NO_KNOWN Submitted by: Ambry Genetics, G2P, Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -4 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DIP2B | ENST00000301180.10 | c.723C>A | p.Asp241Glu | missense_variant | Exon 6 of 38 | 5 | NM_173602.3 | ENSP00000301180.5 | ||
DIP2B | ENST00000546719.1 | n.500C>A | non_coding_transcript_exon_variant | Exon 5 of 7 | 1 | |||||
DIP2B | ENST00000549620.5 | n.879C>A | non_coding_transcript_exon_variant | Exon 6 of 8 | 1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD2 exomes AF: 0.00000796 AC: 2AN: 251390 AF XY: 0.0000147 show subpopulations
GnomAD4 exome AF: 0.00000342 AC: 5AN: 1461880Hom.: 0 Cov.: 30 AF XY: 0.00000550 AC XY: 4AN XY: 727240 show subpopulations
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.723C>A (p.D241E) alteration is located in exon 6 (coding exon 6) of the DIP2B gene. This alteration results from a C to A substitution at nucleotide position 723, causing the aspartic acid (D) at amino acid position 241 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at